Skip to main content
. Author manuscript; available in PMC: 2012 Jan 25.
Published in final edited form as: Eur J Pharmacol. 2011 Jan 25;651(1-3):96–105. doi: 10.1016/j.ejphar.2010.10.085

Fig. 2.

Fig. 2

Effects of 3 and 10 μg O-2050 (i.c.v. at a volume of 5 μl) in combination with dimethyl sulfoxide (i.v.) [left panels] or with 3 mg/kg Δ9-tetrahydrocannabinol (i.v.) [right panels] on suppression of spontaneous activity (top panels), antinociception (middle panels) and hypothermia (bottom panels). Each bar represents the mean (± S.E.M.) of data from 4-5 mice.